Ribonucleases as a novel pro-apoptotic anticancer strategy: Review of the preclinical and clinical data for ranpirnase

John Costanzi, David Sidransky, Ami Navon, Howard Goldsweig

Research output: Contribution to journalReview articlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Ribonucleases as a novel pro-apoptotic anticancer strategy: Review of the preclinical and clinical data for ranpirnase'. Together they form a unique fingerprint.

Medicine & Life Sciences